Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
GE HealthCare considering stake sale in China division: report
Bloomberg said the company is exploring its options for a deal, which could value its total China assets in the billions of dollars.
Conor Hale
Sep 18, 2025 2:30pm
Biogen inks $85M Alcyone buyout to acquire drug delivery tech
Sep 18, 2025 10:30am
Roche becomes MASH player via $3.5B deal for 89bio, ph. 3 drug
Sep 18, 2025 5:02am
CSL pays $117M for option on phase 3 blood clotting specialist
Sep 16, 2025 4:31am
GE HealthCare to acquire brain MRI AI developer icometrix
Sep 10, 2025 11:45am
Novartis spends $1.4B for Tourmaline, CV med that wowed in ph. 2
Sep 9, 2025 4:28am
